Evaluation of SARS-CoV-2 Rapid Antigen Tests in Use on the Isle of Youth, Cuba.

IF 1.8 4区 医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Medicc Review Pub Date : 2022-05-16 DOI:10.37757/mr2022.v24.n2.3
Saylí González-Fiallo, Idorka Mena-Rodríguez, Percy Castro-Batista, Víctor M. Doeste-Hernández, Viviana Louit-Laborit
{"title":"Evaluation of SARS-CoV-2 Rapid Antigen Tests in Use on the Isle of Youth, Cuba.","authors":"Saylí González-Fiallo, Idorka Mena-Rodríguez, Percy Castro-Batista, Víctor M. Doeste-Hernández, Viviana Louit-Laborit","doi":"10.37757/mr2022.v24.n2.3","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\nThe use of various diagnostic techniques is increasingly common in pandemic scenarios. It is important to update evaluations of their metric properties in different times and settings.\n\n\nOBJECTIVE\nEvaluate metric properties of a SARS-CoV-2 rapid antigen test relative to a reference standard.\n\n\nMETHODS\nWe carried out a prospective evaluation study of the SARS-CoV-2 rapid antigen test as compared to the RT-PCR test, which is considered the reference standard. Our sample was comprised of 778 individuals, and we calculated sensitiv- ity, specificity, predictive values, prevalence and validity indices.\n\n\nRESULTS\nOf the total 778 samples, 70 were true positives, 658 were true negatives, and 27 were false negatives when compared to RT-PCR test results. We obtained a sensitivity of 75.3% (95% CI = 65.96-84.50); a specificity of 96.1% (95% CI = 94.53-97.59); 72.2% for positive predictive value, and 96.6% for negative predictive value. The estimated preva- lence was 11.9% and the validity index was 93.6%.\n\n\nCONCLUSIONS\nThe index values validate use of the SARS- CoV-2 rapid antigen test until prevalence falls below 2.5%, since as SARS-CoV-2 infection prevalence decreases, so does the predictive value of the PCR result. The use of the SARS-CoV-2 rapid antigen test on the Isle of Youth, Cuba, was decisive in the pandemic's clinical- epidemiological management.","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"137 1","pages":"15-19"},"PeriodicalIF":1.8000,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicc Review","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37757/mr2022.v24.n2.3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION The use of various diagnostic techniques is increasingly common in pandemic scenarios. It is important to update evaluations of their metric properties in different times and settings. OBJECTIVE Evaluate metric properties of a SARS-CoV-2 rapid antigen test relative to a reference standard. METHODS We carried out a prospective evaluation study of the SARS-CoV-2 rapid antigen test as compared to the RT-PCR test, which is considered the reference standard. Our sample was comprised of 778 individuals, and we calculated sensitiv- ity, specificity, predictive values, prevalence and validity indices. RESULTS Of the total 778 samples, 70 were true positives, 658 were true negatives, and 27 were false negatives when compared to RT-PCR test results. We obtained a sensitivity of 75.3% (95% CI = 65.96-84.50); a specificity of 96.1% (95% CI = 94.53-97.59); 72.2% for positive predictive value, and 96.6% for negative predictive value. The estimated preva- lence was 11.9% and the validity index was 93.6%. CONCLUSIONS The index values validate use of the SARS- CoV-2 rapid antigen test until prevalence falls below 2.5%, since as SARS-CoV-2 infection prevalence decreases, so does the predictive value of the PCR result. The use of the SARS-CoV-2 rapid antigen test on the Isle of Youth, Cuba, was decisive in the pandemic's clinical- epidemiological management.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在古巴青年岛使用的SARS-CoV-2快速抗原检测的评价
在大流行的情况下,各种诊断技术的使用越来越普遍。在不同的时间和设置下更新其度量属性的评估是很重要的。目的相对于参考标准评价SARS-CoV-2快速抗原检测的计量特性。方法对SARS-CoV-2快速抗原检测方法与RT-PCR检测方法进行前瞻性评价研究,后者可作为参考标准。我们的样本由778个个体组成,我们计算了敏感性、特异性、预测值、患病率和有效性指标。结果与RT-PCR检测结果比较,778份样本中,真阳性70份,真阴性658份,假阴性27份。我们获得了75.3%的灵敏度(95% CI = 65.96-84.50);特异性为96.1% (95% CI = 94.53-97.59);阳性预测值为72.2%,阴性预测值为96.6%。估计患病率为11.9%,效度指数为93.6%。结论随着SARS-CoV-2感染流行率的降低,PCR结果的预测值也随之降低,因此,在SARS-CoV-2感染流行率低于2.5%之前,该指标值是有效的。在古巴青年岛使用SARS-CoV-2快速抗原检测对大流行的临床流行病学管理起了决定性作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medicc Review
Medicc Review PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
3.30
自引率
9.50%
发文量
49
审稿时长
>12 weeks
期刊介绍: Uphold the highest standards of ethics and excellence, publishing open-access articles in English relevant to global health equity that offer the best of medical, population health and social sciences research and perspectives by Cuban and other developing-country professionals.
期刊最新文献
Executive Summary: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba. COVID-19, Viruses and Dementia. Full Technical Report: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba. Health Care is a Right, Not a Commodity: The Legacy of Dr Paul Farmer MD PhD. Validation of a New Diagnostic Index to Determine Metabolic Obesity Phenotypes in Normal-Weight Women in Early Pregnancy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1